Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments. Although the etiology of ulcerative colitis (UC) d...

Full description

Saved in:
Bibliographic Details
Main Authors: Remo Panaccione, Richard N Fedorak, Guy Aumais, Edmond-Jean Bernard, Charles N Bernstein, Alain Bitton, Ken Croitoru, Levinus A Dieleman, Robert Enns, Brian G Feagan, Denis Franchimont, Gordon R Greenberg, Anne-Marie Griffiths, John K Marshall, Pierre Pare, Sunil Patel, Robert Penner, Craig Render, Ernest Seidman, A Hillary Steinhart
Format: Article
Language:English
Published: Wiley 2008-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2008/493405
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items